Masitinib as a neuroprotective agent: a scoping review of preclinical and clinical evidence

ConclusionThe current evidence suggests a promising therapeutic benefit of masitinib in neurodegenerative diseases. However, further research is necessary to validate and expand upon these findings, particularly regarding the precise mechanisms through which masitinib exerts its therapeutic effects. Future studies should also focus on addressing the safety concerns associated with masitinib use.
Source: Neurological Sciences - Category: Neurology Source Type: research